Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Lascano, N. Kaipust, J. Lanfranco, M. Cearras, F. Caceres, C. Bidot, M. Gonzalez, W. Jy, Y. Ahn, M. Salathe, M. Campos (Miami, United States Of America). Circulating microparticles in COPD exacerbations. Eur Respir J 2010; 36: Suppl. 54, 3835

Member's Comments

No comment yet.

Related content which might interest you: Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Time course of serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Time course of sputum and serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 464s Year: 2005 Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Evaluation of markers for exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005 Circulating fibrocytes in patients with chronic obstructive asthma Source: Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases Year: 2009 Leptin during COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Corticosteroids and exacerbations of COPD Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Procalcitonin use in acute exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Change in inflammation during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 15s Year: 2005 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 IL-18 in infectious exacerbations of COPD Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011